Cherwell launches new support hub for growing Redipor® prepared media distributor network Kumar Jeetendra | August 6, 2020 Cherwell Laboratories, specialist suppliers of environmental monitoring and process validation solutions for the pharmaceutical and related industries, has launched a Redipor® prepared media distributor resource centre website. Developing this online knowledge hub supports Cherwell’s growing international distribution network within Europe and now Asia. This means that all Redipor microbiological media customers will receive quality support …
New medication RLF-100 shows sensational outcomes for basic COVID-19 patients Kumar Jeetendra | August 6, 2020 Doctors in a hospital have used a brand new drug called RLF-100, also called aviptadil, which has resulted in rapid recovery from respiratory failure in critically ill COVID-19 patients. The drug has been approved by the FDA for emergency use at multiple clinical sites in patients that are too sick to input the FDA’s Stage …
Covid-19 Antibody Rapid Serology Test by Americal Screening Kumar Jeetendra | August 6, 2020 American Idol, Shreveport, La, has included a covid-19 IgG/IgM rapid test to its inventory. The in vitro immunoassay, that has been allowed emergency use authorization (EUA) from the FDA, is created for the qualitative and direct discovery of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is simple to …
Biomedical scientists make counterfeit organelles to control biological function in cells Kumar Jeetendra | August 7, 2020 Biomedical engineers at Duke University have shown a way of controlling the phase separation of an emerging class of proteins to create artificial membrane-less organelles in human cells. The progress, similar to controlling how vinegar forms droplets within oil, creates chances for engineering artificial structures to modulate present cell functions or produce entirely new behaviours …
BD Extended HPV Testing Gets FDA Approval Kumar Jeetendra | August 7, 2020 BD (Becton, Dickinson and Company), Franklin Lakes, NJ, received a premarket approval (PMA) supplement in the FDA for an Enlarged version of its BD Onclarity human papillomavirus (HPV) assay. The PMA supplement comprises the expansion for genotype reporting past HPV genotypes 16, 18, and 45 to comprise types 31, 51, 52, 33/58, 35/39/68, and 56/59/66, …
Researchers disentangle how safe immune system glitches in extreme COVID-19 cases Kumar Jeetendra | August 7, 2020 Unlike earlier studies, scientists have found that severe COVID-19 does not solely bring about a hyperactive immune system, but instead the body’s defense response is captured in a constant loop of activation and inhibition, an advance that may help develop superior therapeutics to combat the deadly illness. The researchers, such as those from the Center …
Pfizer signs deal to produce and flexibly Gilead’s remdesivir for COVID-19 treatment Kumar Jeetendra | August 7, 2020 The US drugmaker would provide contract manufacturing services in its facility in Kansas to create the medication. Pfizer Inc said on Friday it signed up a multi-year agreement with Gilead Sciences Inc to manufacture and provide the organization’s antiviral drug remdesivir for COVID-19 patients. The US drugmaker would provide contract manufacturing services at its center …
New test can pinpoint which individuals with gonorrhea can be relieved with ciprofloxacin Kumar Jeetendra | August 7, 2020 A test made by UCLA researchers could pinpoint which individuals with gonorrhea will react successfully to the inexpensive oral antibiotic ciprofloxacin, which had formerly been sidelined over concerns the bacterium that causes the disease was becoming resistant to it. In study published in the peer-reviewed journal Clinical Infectious Diseases, a UCLA-led team found that of …
Jubilant Life Sciences presents 1,000 vials of Remdesivir to Uttar Pradesh CM Yogi Adityanath Kumar Jeetendra | August 8, 2020 Drug firm Jubilant Life Sciences on Saturday said it has introduced 1,000 vials of antiviral drug Remdesivir that it sells under the brand name’JUBI-R’ into Uttar Pradesh Chief Minister Yogi Adityanath. The drug has been made accessible to over 1,000 hospitals supplying COVID-19 treatment in India throughout the organization’s distribution system, Jubilant Life Sciences said …
Relief Therapeutics sees 60-70% possibility of COVID-19 medication endorsement Kumar Jeetendra | August 8, 2020 Relief Therapeutics’ chairman said that he was optimistic that its RLF-100 (aviptadil) drug will acquire approval for treating COVID-19 patients in a matter of months. The Swiss group owns the rights to the drug in the United States and Europe. Its US spouse NeuroRx is conducting multicentre clinical trials in patients that are severely ill …
Researchers distinguish cell structure that may assume basic job in coronavirus replication Kumar Jeetendra | August 8, 2020 Scientists have identified a structure in host cells which the novel coronavirus likely uses to synthesise elements that will be assembled into completely infectious germs, an advance that might lead to the development of new medications against COVID-19. The analysis, published in the journal Science Advances, uncovers a coronavirus-specific structure in cells, which might work …
Swiss Parenterals Limited received European Union (EU) GMP approval Kumar Jeetendra | August 8, 2020 India’s leading manufacturer of Sterile Injectables company to soon enter the EU markets with various range of injectables and expand gradually. Swiss Parenterals Limited, one of the India’s leading sterile injectable manufacturer has received the European Union (EU) GMP for its two state of the art manufacturing facilities located at Bavla in Gujarat. The certification …
